Since aggressive endothelial repair induces a shortage of CD34-positive cells due to consumption, participants with established atherosclerosis (CIMT ≥ 1.1 mm) could have lower levels of circulating CD34-positive cells. The gene discussed is CD34; the disease is atherosclerosis.